Planned OU trials test opaganib after CAR T-cell therapy for high-risk myeloma
A National Cancer Institute grant will fund planned OU trials testing whether opaganib can enhance CAR T-cell activity against ultra-high-risk ...
A National Cancer Institute grant will fund planned OU trials testing whether opaganib can enhance CAR T-cell activity against ultra-high-risk ...
A new study identifies UBA1 as a primary candidate biomarker for multiple myeloma by integrating ubiquitination and liquid-liquid phase separation ...
A consumer-informed Australian pilot study found that an existing group mental health program significantly improved wellbeing and empowerment among people ...
Chimeric antigen receptor T cell therapy has redefined the treatment of multiple myeloma, offering deep and durable remissions to patients ...
A phase 2 trial found that ultra-low-dose radiation therapy delivered in one or two sessions relieved painful bone lesions in ...
A new computational study suggests that next-generation CRBN E3 ligase modulators, particularly CC-885, may hold the key to overcoming mutation-driven ...
A retrospective cohort study using the MIMIC-IV database found that elevated blood urea nitrogen within 24 hours of ICU admission ...
A qualitative study of multiple myeloma patients preparing for autologous stem cell transplants finds that financial toxicity surfaces indirectly through ...
A new method-comparison study finds that a domestic Chinese latex-enhanced immunoturbidimetric serum free light chain assay shows precision and agreement ...
Researchers adapted a thermodynamics-based modeling language from ecology to reproduce the full life cycle of the adaptive immune response across ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine